171 related articles for article (PubMed ID: 19149898)
1. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a.
Becker TM; Haferkamp S; Dijkstra MK; Scurr LL; Frausto M; Diefenbach E; Scolyer RA; Reisman DN; Mann GJ; Kefford RF; Rizos H
Mol Cancer; 2009 Jan; 8():4. PubMed ID: 19149898
[TBL] [Abstract][Full Text] [Related]
2. BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.
Tu Z; Zhuang X; Yao YG; Zhang R
Mol Cell Biol; 2013 May; 33(9):1819-29. PubMed ID: 23438604
[TBL] [Abstract][Full Text] [Related]
3. BRG1 expression is increased in human cutaneous melanoma.
Lin H; Wong RP; Martinka M; Li G
Br J Dermatol; 2010 Sep; 163(3):502-10. PubMed ID: 20491765
[TBL] [Abstract][Full Text] [Related]
4. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
[TBL] [Abstract][Full Text] [Related]
5. The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.
Seo S; Richardson GA; Kroll KL
Development; 2005 Jan; 132(1):105-15. PubMed ID: 15576411
[TBL] [Abstract][Full Text] [Related]
6. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
8. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated with the silencing of NANOG and changes in the levels of chromatin proteins.
Squillaro T; Severino V; Alessio N; Farina A; Di Bernardo G; Cipollaro M; Peluso G; Chambery A; Galderisi U
Cell Cycle; 2015; 14(8):1315-26. PubMed ID: 25724006
[TBL] [Abstract][Full Text] [Related]
9. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
Vachtenheim J; Ondrusová L; Borovanský J
Biochem Biophys Res Commun; 2010 Feb; 392(3):454-9. PubMed ID: 20083088
[TBL] [Abstract][Full Text] [Related]
10. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
11. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells.
Laurette P; Strub T; Koludrovic D; Keime C; Le Gras S; Seberg H; Van Otterloo E; Imrichova H; Siddaway R; Aerts S; Cornell RA; Mengus G; Davidson I
Elife; 2015 Mar; 4():. PubMed ID: 25803486
[TBL] [Abstract][Full Text] [Related]
13. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
14. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
Betz BL; Strobeck MW; Reisman DN; Knudsen ES; Weissman BE
Oncogene; 2002 Aug; 21(34):5193-203. PubMed ID: 12149641
[TBL] [Abstract][Full Text] [Related]
15. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract][Full Text] [Related]
16. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.
Hoffman GR; Rahal R; Buxton F; Xiang K; McAllister G; Frias E; Bagdasarian L; Huber J; Lindeman A; Chen D; Romero R; Ramadan N; Phadke T; Haas K; Jaskelioff M; Wilson BG; Meyer MJ; Saenz-Vash V; Zhai H; Myer VE; Porter JA; Keen N; McLaughlin ME; Mickanin C; Roberts CW; Stegmeier F; Jagani Z
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):3128-33. PubMed ID: 24520176
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
18. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
[TBL] [Abstract][Full Text] [Related]
19. Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations.
Becker TM; Rizos H; de la Pena A; Leclercq IA; Woodruff S; Kefford RF; Mann GJ
Biochem Biophys Res Commun; 2005 Jul; 332(3):873-9. PubMed ID: 15913553
[TBL] [Abstract][Full Text] [Related]
20. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
